Evidence map›Paper›PMID 28737258›Full record

ArticleObesity (Silver Spring, Md.)2017

Preclinical Alterations in Myocardial Microstructure in People with Metabolic Syndrome.

Jennifer E Ho, Youssef Rahban, Harpaul Sandhu, Pranoti G Hiremath, Nir Ayalon, Fuzhong Qin, Alejandro J Perez, Jill Downing, Deepa M Gopal, Susan Cheng and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Obesity (Silver Spring, Md.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Jennifer E HoCardiovascular Research Center and Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-7987-4768
Youssef RahbanCardiovascular Center, Tufts Medical Center, Boston, Massachusetts, USA.
Harpaul SandhuTemple Heart and Vascular Institute, Temple University, Philadelphia, Pennsylvania, USA.
Pranoti G HiremathHarvard Medical School, Boston, Massachusetts, USA.
Nir AyalonCardiovascular Medicine Section, Department of Medicine, Boston University, Boston, Massachusetts, USA.
Fuzhong QinWhitaker Cardiovascular Institute, Boston University, Boston, Massachusetts, USA.
Alejandro J PerezCardiovascular Medicine Section, Department of Medicine, Boston University, Boston, Massachusetts, USA.
Jill DowningCardiovascular Medicine Section, Department of Medicine, Boston University, Boston, Massachusetts, USA.
Deepa M GopalCardiovascular Medicine Section, Department of Medicine, Boston University, Boston, Massachusetts, USA.
Susan ChengCardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Wilson S ColucciCardiovascular Medicine Section, Department of Medicine, Boston University, Boston, Massachusetts, USA.
Boston University · USBrigham and Women's Hospital · USHarvard University · USMassachusetts General Hospital · USTemple University · USTufts Medical Center · US

Funding

Cardiac microstructure and the immune-inflammatory response to SARS-CoV-2R01HL131532 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI CHENG, SUSAN, LI, DEBIAO · 2016 to 2025
$6.6M
The Role of Galectin-3 in Cardiac Remodeling and Heart FailureK23HL116780 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HO, JENNIFER E · 2013 to 2017
$832k
NHLBI NIH HHS K23 HL116780NHLBI NIH HHS R01 HL131532
6 · The paper itself

Abstract

objectiveMetabolic syndrome (MetS) can lead to myocardial fibrosis, diastolic dysfunction, and eventual heart failure. This study evaluated alterations in myocardial microstructure in people with MetS by using a novel algorithm to characterize ultrasonic signal intensity variation.

methodsAmong 254 participants without existing cardiovascular disease (mean age 42 ± 11 years, 75% women), there were 162 with MetS, 47 with obesity without MetS, and 45 nonobese controls. Standard echocardiography was performed, and a novel validated computational algorithm was used to investigate myocardial microstructure based on sonographic signal intensity and distribution. The signal intensity coefficient (SIC [left ventricular microstructure]) was examined.

resultsThe SIC was significantly higher in people with MetS compared with people with (P < 0.001) and without obesity (P = 0.04), even after adjustment for age, sex, body mass index, hypertension, diabetes mellitus, and the ratio of triglyceride (TG) to high-density lipoprotein (HDL) cholesterol (P < 0.05 for all). Clinical correlates of SIC included TG concentrations (r = 0.21, P = 0.0007) and the TG/HDL ratio (r = 0.2, P = 0.001).

conclusionsThis study's findings suggest that preclinical MetS and dyslipidemia in particular are associated with altered myocardial signal intensity variation. Future studies are needed to determine whether the SIC may help detect subclinical diseases in people with metabolic disease, with the ultimate goal of targeting preventive efforts.

Indexed as

AdultBody Mass IndexCholesterol, HDLDiabetes MellitusEchocardiographyFemaleHumansLipidsMaleMetabolic SyndromeMiddle AgedMyocardiumObesityRisk FactorsTriglyceridesCholesterol, HDLLipidsTriglycerides

Identifiers

PMID28737258
PMCPMC5578717
OpenAlexW2737473752

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.